Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.0Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-0.9EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)23.7Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,100,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XTL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

XTL is held by these investors:

XTL: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about XTL:

    News about XTL:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Can Stock Market Keep Rising As Summer Doldrums Loom? Jun 01 2017
    XTL Biopharmaceuticals Appoints Mr. Alex Rabinovich to its Board of Directors Apr 27 2017
    XTL Biopharmaceuticals Unveils Expanded hCDR1 Preclinical Data for the Treatment of Sjögren’s... Apr 05 2017
    XTL Biopharmaceuticals Announces Closing of $2.8 Million Private Placement From Existing Investors Mar 22 2017
    5 Biggest Winners from the Fed Rate Hike Mar 16 2017
    XTL Biopharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement Mar 01 2017
    XTL Biopharmaceuticals Expands Clinical Advisory Board to Support Phase II Study of HCDR1 in... Feb 13 2017
    Telecom ETFs: What Lies Ahead in 2017? Feb 07 2017
    ETFs That Sound Alike Are Often Different Jan 26 2017
    XTL Biopharmaceuticals Announces Ratio Change of its Depositary Receipt Program Jan 25 2017
    XTL Biopharmaceuticals to Present at Biotech Showcase Dec 19 2016
    Dow closes in on 20K mark Dec 13 2016
    XTL Biopharmaceuticals Receives NASDAQ Notification Regarding Minimum Bid Requirements Nov 09 2016
    After Friday's Swoon, Should You Run for the Exits? Sep 11 2016
    XTL Biopharmaceuticals Announces the European Patent Office has Issued a Patent for its Lupus Drug... Sep 07 2016
    Top ETFs In Neglected Telecom Sector Sep 01 2016
    XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1 Aug 11 2016
    Dow ETF Treads Water As Key Blue Chips Post Results That Lack Salt Jul 26 2016
    Corporate America is under pressure to deliver the earnings ‘hockey stick’ Jul 14 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat